Books > Science & Mathematics > Science: general issues > Science funding & policy
|
Buy Now
Debating Modern Medical Technologies - The Politics of Safety, Effectiveness, and Patient Access (Hardcover)
Loot Price: R1,595
Discovery Miles 15 950
|
|
Debating Modern Medical Technologies - The Politics of Safety, Effectiveness, and Patient Access (Hardcover)
Expected to ship within 10 - 15 working days
|
Donate to Against Period Poverty
Total price: R1,615
Discovery Miles: 16 150
|
This book analyzes policy fights about what counts as good evidence
of safety and effectiveness when it comes to new health care
technologies in the United States and what political decisions mean
for patients and doctors. Medical technologies often promise to
extend and improve quality of life but come with many questions:
Are they safe and effective? Are they worth the cost? When should
they be allowed on the market, and when should Medicare, Medicaid,
and private insurance companies be required to pay for drugs,
devices, and diagnostic tests? Using case studies of disputes about
the value of mammography screening; genetic testing for disease
risk; brain imaging technologies to detect biomarkers associated
with Alzheimer's disease; cell-based therapies; and new, expensive
drugs, Maschke and Gusmano illustrate how scientific disagreements
about what counts as good evidence of safety and effectiveness are
often swept up in partisan fights over health care reform and
battles among insurance and health care companies, physicians, and
patient advocates. Debating Modern Medical Technologies: The
Politics of Safety, Effectiveness, and Patient Access reveals
stakeholders' differing values and interests regarding patient
choice, physician autonomy, risk assessment, government
intervention in medicine and technology assessment, and scientific
innovation as a driver of national and global economies. It will
help readers to understand the nature and complexity of past and
current policy disagreements and their effects on patients. Helps
readers to understand the political, economic, and ideological
dimensions of disputes about health technology assessment and the
implications of various policy approaches for patients and the
health care system Includes discussion of disputes related to hot
topics such as stem cell therapies, mammography screening, genomic
tests, breast cancer drugs, and Hepatitis C medications Discusses
interest group pressure on government from large pharmaceutical
companies and medical device manufacturers Connects to current
political rhetoric about speeding up the availability of technology
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|